Lee Ratner
#126,087
Most Influential Person Now
Researcher
Lee Ratner's AcademicInfluence.com Rankings
Lee Ratnerengineering Degrees
Engineering
#4143
World Rank
#5313
Historical Rank
Electrical Engineering
#1029
World Rank
#1105
Historical Rank
Lee Ratnercomputer-science Degrees
Computer Science
#5298
World Rank
#5597
Historical Rank
Computational Linguistics
#704
World Rank
#716
Historical Rank
Machine Learning
#1352
World Rank
#1373
Historical Rank
Artificial Intelligence
#1587
World Rank
#1617
Historical Rank
Download Badge
Engineering Computer Science
Lee Ratner's Degrees
- PhD Computer Science Stanford University
- Masters Electrical Engineering University of California, Berkeley
- Bachelors Computer Engineering University of California, Berkeley
Similar Degrees You Can Earn
Why Is Lee Ratner Influential?
(Suggest an Edit or Addition)Lee Ratner's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Complete nucleotide sequence of the AIDS virus, HTLV-III (1985) (2071)
- The Vpr protein of human immunodeficiency virus type 1 influences nuclear localization of viral nucleic acids in nondividing host cells. (1994) (952)
- Sensitivity of Human Immunodeficiency Virus Type 1 to the Fusion Inhibitor T-20 Is Modulated by Coreceptor Specificity Defined by the V3 Loop of gp120 (2000) (745)
- Myristoylation-dependent replication and assembly of human immunodeficiency virus 1. (1990) (631)
- Definition, prognostic factors, treatment, and response criteria of adult T-cell leukemia-lymphoma: a proposal from an international consensus meeting. (2009) (499)
- Multidrug resistance transporters and modulation (2000) (414)
- Viral protein R regulates nuclear import of the HIV‐1 pre‐integration complex (1998) (385)
- The sor gene of HIV-1 is required for efficient virus transmission in vitro. (1987) (382)
- Development of leukemia in mice transgenic for the tax gene of human T-cell leukemia virus type I. (1995) (371)
- Complete nucleotide sequences of functional clones of the AIDS virus. (1987) (321)
- A molecular clone of HTLV-III with biological activity (1985) (299)
- Macrophage tropism determinants of human immunodeficiency virus type 1 in vivo (1992) (293)
- Human immunodeficiency virus type 1 viral protein R localization in infected cells and virions (1993) (290)
- Chemotherapy for human immunodeficiency virus-associated non-Hodgkin's lymphoma in combination with highly active antiretroviral therapy. (2001) (287)
- Molecular biology of human T-lymphotropic retroviruses. (1985) (286)
- Bioluminescence imaging of myeloperoxidase activity in vivo (2009) (282)
- Identification of human immunodeficiency virus type 1 Gag protein domains essential to membrane binding and particle assembly (1994) (271)
- Identification of a determinant within the human immunodeficiency virus 1 surface envelope glycoprotein critical for productive infection of primary monocytes. (1991) (268)
- Relationship of human immunodeficiency virus type 1 sequence heterogeneity to stage of disease. (1992) (255)
- Rituximab plus concurrent infusional EPOCH chemotherapy is highly effective in HIV-associated B-cell non-Hodgkin lymphoma. (2010) (229)
- Human immunodeficiency virus type 1 negative factor is a transcriptional silencer. (1989) (228)
- Immortalization of CD4+ and CD8+ T Lymphocytes by Human T-Cell Leukemia Virus Type 1 Tax Mutants Expressed in a Functional Molecular Clone (1999) (221)
- Killing HIV-infected cells by transduction with an HIV protease-activated caspase-3 protein (1999) (221)
- Membrane binding of human immunodeficiency virus type 1 matrix protein in vivo supports a conformational myristyl switch mechanism (1997) (217)
- Viral Protein R Regulates Docking of the HIV-1 Preintegration Complex to the Nuclear Pore Complex* (1998) (216)
- Infectious mutants of HTLV-III with changes in the 3' region and markedly reduced cytopathic effects. (1986) (213)
- Sensitivity of Human Immunodeficiency Virus Type 1 to Fusion Inhibitors Targeted to the gp41 First Heptad Repeat Involves Distinct Regions of gp41 and Is Consistently Modulated by gp120 Interactions with the Coreceptor (2001) (186)
- Human Immunodeficiency Virus Type 1 Coreceptor Switching: V1/V2 Gain-of-Fitness Mutations Compensate for V3 Loss-of-Fitness Mutations (2006) (179)
- Selective ablation of human T-cell lymphotropic virus type 1 p12I reduces viral infectivity in vivo. (1998) (176)
- Interferon action: two distinct pathways for inhibition of protein synthesis by double-stranded RNA. (1978) (168)
- Transformation of NIH 3T3 cells by a human c-sis cDNA clone (1984) (155)
- Rapid Progression of Adult T-Cell Leukemia-Lymphoma after PD-1 Inhibitor Therapy. (2018) (154)
- Matrix metalloproteinase inhibitor COL-3 in the treatment of AIDS-related Kaposi's sarcoma: a phase I AIDS malignancy consortium study. (2002) (153)
- Human-proto-oncogene nucleotide sequences corresponding to the transforming region of simian sarcoma virus. (1984) (149)
- A leucine triplet repeat sequence (LXX)4 in p6gag is important for Vpr incorporation into human immunodeficiency virus type 1 particles (1995) (148)
- Treatment factors affecting outcomes in HIV-associated non-Hodgkin lymphomas: a pooled analysis of 1546 patients. (2013) (147)
- Analysis of the Critical Domain in the V3 Loop of Human Immunodeficiency Virus Type 1 gp120 Involved in CCR5 Utilization (1999) (140)
- Functional Role of pX Open Reading Frame II of Human T-Lymphotropic Virus Type 1 in Maintenance of Viral Loads In Vivo (2000) (138)
- Construction and characterization of infectious human T-cell leukemia virus type 1 molecular clones. (1994) (129)
- Revised Adult T-Cell Leukemia-Lymphoma International Consensus Meeting Report (2019) (127)
- Dual regulation of silent and productive infection in monocytes by distinct human immunodeficiency virus type 1 determinants (1992) (119)
- Characterization of long terminal repeat sequences of HTLV-III. (1985) (118)
- Human immunodeficiency virus type 1 Nef protein inhibits NF-kappa B induction in human T cells (1992) (116)
- Limited sequence variation in human T-lymphotropic virus type 1 isolates from North American and African patients. (1991) (110)
- Human T-Lymphotropic Virus Type 1 Open Reading Frame I p12I Is Required for Efficient Viral Infectivity in Primary Lymphocytes (2000) (109)
- Transforming potential of human c-sis nucleotide sequences encoding platelet-derived growth factor. (1984) (107)
- Actin Cytoskeletal Reorganizations and Coreceptor-Mediated Activation of Rac during Human Immunodeficiency Virus-Induced Cell Fusion (2004) (105)
- Role of Abl Kinase and the Wave2 Signaling Complex in HIV-1 Entry at a Post-Hemifusion Step (2010) (104)
- The role of NF-κB-1 and NF-κB-2-mediated resistance to apoptosis in lymphomas (2006) (103)
- Nucleotide sequence analysis of isolates of human T-lymphotropic virus type 1 of diverse geographical origins. (1991) (103)
- Transactivation induced by human T-lymphotropic virus type III (HTLV III) maps to a viral sequence encoding 58 amino acids and lacks tissue specificity. (1986) (102)
- Chemotherapy consisting of doxorubicin, bleomycin, vinblastine, and dacarbazine with granulocyte-colony-stimulating factor in HIV-infected patients with newly diagnosed Hodgkin's disease: a prospective, multi-institutional AIDS clinical trials group study (ACTG 149). (2000) (100)
- Human T-Cell Leukemia Virus Type 1 pX-I and pX-II Open Reading Frames Are Dispensable for the Immortalization of Primary Lymphocytes (1998) (99)
- The contribution of NF-kappa B activity to spontaneous proliferation and resistance to apoptosis in human T-cell leukemia virus type 1 Tax-induced tumors. (2001) (99)
- Interferon, double-stranded RNA and RNA degradation. Fractionation of the endonucleaseINT system into two macromolecular components; role of a small molecule in nuclease activation. (1978) (99)
- Human immunodeficiency virus type 1 tropism for T-lymphoid cell lines: role of the V3 loop and C4 envelope determinants (1996) (98)
- Viral protein R of human immunodeficiency virus types 1 and 2 is dispensable for replication and cytopathogenicity in lymphoid cells (1989) (97)
- HTLV-III, LAV, ARV are variants of same AIDS virus (1985) (95)
- Cytolytic Nanoparticles Attenuate HIV-1 Infectivity (2013) (94)
- Human T-Cell Lymphotropic Virus Type 1 Open Reading Frame II-Encoded p30II Is Required for In Vivo Replication: Evidence of In Vivo Reversion (2004) (88)
- Foxp3 Represses Retroviral Transcription by Targeting Both NF-κB and CREB Pathways (2006) (88)
- Inhibition of HIV and SIV infectivity by blockade of α-glucosidase activity (1991) (83)
- Human immunodeficiency virus type 1 Nef protein down-regulates transcription factors NF-kappa B and AP-1 in human T cells in vitro after T-cell receptor stimulation (1994) (83)
- Human immunodeficiency virus-associated autoimmune thrombocytopenic purpura: a review. (1989) (82)
- High-dose platinum for the treatment of refractory ovarian cancer. (1981) (82)
- IRF-4 and c-Rel expression in antiviral-resistant adult T-cell leukemia/lymphoma. (2007) (82)
- Induction of the Gαq Signaling Cascade by the Human Immunodeficiency Virus Envelope Is Required for Virus Entry (2008) (81)
- Myristoylation-enhanced binding of the HIV-1 Nef protein to T cell skeletal matrix. (1993) (78)
- Sequences of the 5' portion of the human c-sis gene: characterization of the transcriptional promoter and regulation of expression of the protein product by 5' untranslated mRNA sequences. (1987) (78)
- Animal models for human T-lymphotropic virus type 1 (HTLV-1) infection and transformation (2005) (76)
- How does HTLV-1 cause adult T-cell leukaemia/lymphoma (ATL)? (2015) (76)
- Mechanisms of nanoparticle-mediated siRNA transfection by melittin-derived peptides. (2013) (75)
- HTLV-1 Tax transgenic mice develop spontaneous osteolytic bone metastases prevented by osteoclast inhibition. (2005) (74)
- Cooperative effects of the human immunodeficiency virus type 1 envelope variable loops V1 and V3 in mediating infectivity for T cells (1996) (73)
- AMC 048: modified CODOX-M/IVAC-rituximab is safe and effective for HIV-associated Burkitt lymphoma. (2015) (73)
- Changes in the influence of lymphoma- and HIV-specific factors on outcomes in AIDS-related non-Hodgkin lymphoma. (2015) (71)
- The C-Terminal Proline-Rich Tail of Human Immunodeficiency Virus Type 2 Vpx Is Necessary for Nuclear Localization of the Viral Preintegration Complex in Nondividing Cells (2000) (69)
- Replication of human immunodeficiency virus 1 and Moloney murine leukemia virus is inhibited by different heteroatom-containing analogs of myristic acid. (1989) (68)
- Nucleotide sequence analysis of a variant human T-cell leukemia virus (HTLV-Ib) provirus with a deletion in pX-I (1985) (68)
- Interferon, double-stranded RNA and RNA degradation. Characteristics of an endonuclease activity. (1977) (67)
- Leukemias Associated with Human T‐Cell Lymphotropic Virus Type I in a Non‐Endemic Region (1988) (67)
- Rapid Progression of Adult T-Cell Leukemia/Lymphoma as Tumor Infiltrating Treg Cells after PD-1 Blockade. (2019) (66)
- The HTLV receptor is a widely expressed protein. (2000) (65)
- Role of the carboxy-terminal portion of the HIV-1 transmembrane protein in viral transmission and cytopathogenicity. (1989) (64)
- Arginine residues in the C-terminus of HIV-1 Vpr are important for nuclear localization and cell cycle arrest. (1998) (61)
- Cetuximab Plus Chemoradiotherapy for HIV-Associated Anal Carcinoma: A Phase II AIDS Malignancy Consortium Trial. (2017) (60)
- Human T-Lymphotropic Virus Type 1 Mitochondrion-Localizing Protein p13II Is Required for Viral Infectivity In Vivo (2006) (60)
- Dysregulated myelopoiesis in mice lacking Jak3. (1999) (59)
- North American ATLL has a distinct mutational and transcriptional profile and responds to epigenetic therapies. (2018) (59)
- Phosphorylation of Human Immunodeficiency Virus Type 1 Vpr Regulates Cell Cycle Arrest (2000) (59)
- Effects of the proteasome inhibitor PS-341 on tumor growth in HTLV-1 Tax transgenic mice and Tax tumor transplants. (2004) (58)
- In vitro CD4+ lymphocyte transformation and infection in a rabbit model with a molecular clone of human T-cell lymphotrophic virus type 1 (1996) (58)
- Glucosidase inhibitors for treatment of HIV-1 infection. (1992) (58)
- Limited sequence heterogeneity among biologically distinct human immunodeficiency virus type 1 isolates from individuals involved in a clustered infectious outbreak. (1990) (57)
- HIV-1 Nef protein inhibits the recruitment of AP-1 DNA-binding activity in human T-cells. (1993) (57)
- Nucleotide sequence of transforming human c-sis cDNA clones with homology to platelet-derived growth factor. (1985) (57)
- The role of NF-{kappa}B-1 and NF-{kappa}B-2-mediated resistance to apoptosis in lymphomas. (2006) (55)
- Enhanced tumorigenesis in HTLV-1 tax-transgenic mice deficient in interferon-gamma. (2004) (55)
- Cancer in People Living With HIV, Version 1.2018, NCCN Clinical Practice Guidelines in Oncology. (2018) (54)
- Particle Size Determinants in the Human Immunodeficiency Virus Type 1 Gag Protein (1998) (54)
- The mitogenic activity of human T-cell leukemia virus type I is T-cell associated and requires the CD2/LFA-3 activation pathway (1993) (52)
- Incorporation of 12-methoxydodecanoate into the human immunodeficiency virus 1 gag polyprotein precursor inhibits its proteolytic processing and virus production in a chronically infected human lymphoid cell line. (1991) (52)
- Acetylation of the human T-cell leukemia virus type 1 Tax oncoprotein by p300 promotes activation of the NF-kappaB pathway. (2009) (51)
- Conserved cysteine residues in the human immunodeficiency virus type 1 transmembrane envelope protein are essential for precursor envelope cleavage (1992) (51)
- The Tax Protein of Human T-cell Leukemia Virus Type 1 Mediates the Transactivation of the c-sis/Platelet-derived Growth Factor-B Promoter through Interactions with the Zinc Finger Transcription Factors Sp1 and NGFI-A/Egr-1* (1997) (51)
- Temporal regulation of viral and cellular gene expression during human T-lymphotropic virus type I-mediated lymphocyte immortalization (1991) (51)
- Hsp40 Facilitates Nuclear Import of the Human Immunodeficiency Virus Type 2 Vpx-Mediated Preintegration Complex (2007) (50)
- Polymorphism of the 3' open reading frame of the virus associated with the acquired immune deficiency syndrome, human T-lymphotropic virus type III. (1985) (50)
- Human immunodeficiency virus type 1 capsid formation in reticulocyte lysates (1996) (50)
- Proliferation Response to Interleukin-2 and Jak/Stat Activation of T Cells Immortalized by Human T-Cell Lymphotropic Virus Type 1 Is Independent of Open Reading Frame I Expression (1999) (48)
- Regulation of expression of the c-sis proto-oncogene. (1989) (46)
- Integrase inhibitors effective against human T-cell leukemia virus type 1 (2011) (45)
- Cyclin L2 is a critical HIV dependency factor in macrophages that controls SAMHD1 abundance. (2015) (45)
- Human T-Cell Leukemia Virus Type 1 (HTLV-1) Tax Requires CADM1/TSLC1 for Inactivation of the NF-κB Inhibitor A20 and Constitutive NF-κB Signaling (2015) (44)
- Analysis of the function of viral protein X (VPX) of HIV-2. (1989) (43)
- Molecular Determinants of Human T-lymphotropic Virus Type 1 Transmission and Spread (2011) (42)
- Conserved amino acids of the human immunodeficiency virus type 2 Vpx nuclear localization signal are critical for nuclear targeting of the viral preintegration complex in non-dividing cells. (2006) (42)
- Human T-lymphotropic virus type-1 p30 alters cell cycle G2 regulation of T lymphocytes to enhance cell survival (2007) (42)
- Human T Cell Leukemia Virus Reactivation with Progression of Adult T-Cell Leukemia-Lymphoma (2009) (42)
- Role of Human Immunodeficiency Virus Type 1 Matrix Phosphorylation in an Early Postentry Step of Virus Replication (2004) (41)
- AlphaInterferon Inhibits Human T-Cell Leukemia Virus Type 1 Assembly byPreventing Gag Interaction withRafts (2003) (40)
- Attenuation of HIV-1 infectivity by an inhibitor of oligosaccharide processing. (1990) (40)
- Vpx is Critical for SIVmne infection of pigtail macaques (2012) (40)
- Highly localized tracks of human immunodeficiency virus type 1 Nef in the nucleus of cells of a human CD4+ T-cell line. (1993) (40)
- Differences Among HIV-1 Variants in Their Ability to Elicit Secretion of TNF-α1 (2000) (40)
- Antiviral and immunomodulatory treatment for AIDS-related primary central nervous system lymphoma: AIDS Malignancies Consortium pilot study 019. (2006) (39)
- Imaging spontaneous tumorigenesis: inflammation precedes development of peripheral NK tumors. (2009) (39)
- Human T-cell leukemia virus type 1 blunts signaling by interferon alpha. (2008) (39)
- HIV-1 Nef protein downregulation of CD4 surface expression: relevance of the lck binding domain of CD4. (1995) (37)
- Quantification of human T-cell lymphotropic virus type 1 proviral load by quantitative competitive polymerase chain reaction. (1998) (37)
- Evidence for Common Structural Determinants of Human Immunodeficiency Virus Type 1 Coreceptor Activity Provided through Functional Analysis of CCR5/CXCR4 Chimeric Coreceptors (2001) (37)
- Cytokine expression and tumorigenicity of large granular lymphocytic leukemia cells from mice transgenic for the tax gene of human T-cell leukemia virus type I. (1997) (37)
- Role of asparagine-linked glycosylation in human immunodeficiency virus type 1 transmembrane envelope function. (1992) (36)
- Particle assembly and Vpr expression in human immunodeficiency virus type 1-infected cells demonstrated by immunoelectron microscopy. (1994) (36)
- T-cell activation promotes tumorigenesis in inflammation-associated cancer (2009) (36)
- Structure—function relationships of the HIV‐1 envelope V3 loop tropism determinant: evidence for two distinct conformations (1993) (36)
- Demonstration of two distinct cytopathic effects with syncytium formation-defective human immunodeficiency virus type 1 mutants (1991) (36)
- Prevalence of HTLV‐I‐associated T‐cell lymphoma (2001) (34)
- Phase I study of defactinib combined with pembrolizumab and gemcitabine in patients with advanced cancer. (2018) (34)
- Immunoblastic lymphoma of T-cell type in a chronically immunosuppressed renal transplant recipient. (1990) (34)
- Viral Protein U (Vpu)-Mediated Enhancement of Human Immunodeficiency Virus Type 1 Particle Release Depends on the Rate of Cellular Proliferation (2001) (34)
- HIV-2 viral protein X association with the GAG p27 capsid protein. (1994) (34)
- Cell surface proteins binding to recombinant soluble HIV-1 and HIV-2 transmembrane proteins. (1993) (33)
- Engraftment and tumorigenesis of HTLV-1 transformed T cell lines in SCID/bg and NOD/SCID mice. (2002) (33)
- Identification of the nuclear localization signal of human immunodeficiency virus type 2 Vpx. (2003) (32)
- Regulation of human immunodeficiency virus Nef protein by phosphorylation. (1994) (32)
- Suppression of Human T-cell Leukemia Virus I Gene Expression by Pokeweed Antiviral Protein* (2009) (32)
- Deletion of Alu sequences in the fifth c-sis intron in individuals with meningiomas. (1990) (31)
- Human T-cell leukemia virus-associated malignancy. (2016) (31)
- Cytotoxic factors secreted by cells infected by human immunodeficiency virus type I. (1987) (31)
- Oncogenes: their role in neoplastic transformation. (1985) (31)
- Pegylated liposomal doxorubicin, rituximab, cyclophosphamide, vincristine, and prednisone in AIDS-related lymphoma: AIDS Malignancy Consortium Study 047. (2013) (31)
- Wip1 and p53 contribute to HTLV-1 Tax-induced tumorigenesis (2012) (31)
- Nef and LTR sequence variation from sequentially derived human immunodeficiency virus type 1 isolates. (1995) (31)
- Weekly oral etoposide in patients with Kaposi's sarcoma associated with human immunodeficiency virus infection: a phase I multicenter trial of the AIDS Clinical Trials Group. (1995) (30)
- A phase 1/pharmacokinetic study of sunitinib in combination with highly active antiretroviral therapy in human immunodeficiency virus‐positive patients with cancer: AIDS Malignancy Consortium trial AMC 061 (2014) (30)
- Analysis of p53 Inactivation in a Human T-Cell Leukemia Virus Type 1 Tax Transgenic Mouse Model (2001) (30)
- Killing of primary CD4+ T cells by non-syncytium-inducing macrophage-tropic human immunodeficiency virus type 1. (1994) (29)
- Combinations of isoform-targeted histone deacetylase inhibitors and bryostatin analogues display remarkable potency to activate latent HIV without global T-cell activation (2017) (29)
- Combination chemotherapy for ovarian carcinoma with cyclophosphamide, adriamycin, and cis-dichlorodiammineplatinum(II) after failure of initial chemotherapy. (1978) (29)
- Productive infection of CD34+-cell-derived megakaryocytes by X4 and R5 HIV-1 isolates. (2000) (29)
- Mutation of epigenetic regulators TET2 and MLL3 in patients with HTLV-I-induced acute adult T-cell leukemia (2016) (28)
- c-sis/PDGF-B Promoter Transactivation by the Tax Protein of Human T-cell Leukemia Virus Type 1* (1996) (28)
- Alpha Interferon Restricts Human T-Lymphotropic Virus Type 1 and 2 De Novo Infection through PKR Activation (2013) (28)
- Cholesterol dependence of HTLV-I infection. (2005) (28)
- Phase II trials of cetuximab (CX) plus cisplatin (CDDP), 5-fluorouracil (5-FU) and radiation (RT) in immunocompetent (ECOG 3205) and HIV-positive (AMC045) patients with squamous cell carcinoma of the anal canal (SCAC): Safety and preliminary efficacy results. (2012) (28)
- Rapid phenotypic drug susceptibility assay for HIV-1 with a CCR5 expressing indicator cell line. (2000) (27)
- Phase I study of pegylated liposomal doxorubicin and the multidrug-resistance modulator, valspodar (2005) (27)
- Dose-adjusted EPOCH chemotherapy with bortezomib and raltegravir for human T-cell leukemia virus-associated adult T-cell leukemia lymphoma (2016) (26)
- Formation and release of virus-like particles by HIV-1 matrix protein. (1999) (26)
- The HTLV-1 hbz antisense gene indirectly promotes tax expression via down-regulation of p30(II) mRNA. (2011) (26)
- Novel Role for Interleukin-2 Receptor-Jak Signaling in Retrovirus Transmission (2009) (26)
- Human Immunodeficiency Virus Type 2 Vpx-Gag Interaction (1998) (26)
- Impact of Myc in HIV-associated Non-Hodgkin Lymphomas Treated with EPOCH, and Outcomes with Vorinostat (AMC075 Trial). (2020) (26)
- Characterization of replication defects induced by mutations in the basic domain and C-terminus of HIV-1 matrix. (2007) (26)
- The ARF Tumor Suppressor Regulates Bone Remodeling and Osteosarcoma Development in Mice (2010) (26)
- Anti-Vpr Activity of a Yeast Chaperone Protein (2004) (26)
- Targeting HTLV-1 Activation of NFκB in Mouse Models and ATLL Patients (2011) (26)
- Identification of HIV1 determinants for T lymphoid cell line infection. (1993) (25)
- Hepatitis viruses and hepatocellular carcinoma in HIV-infected patients (2002) (25)
- Histone acetyltransferase (HAT) activity of p300 modulates human T lymphotropic virus type 1 p30II-mediated repression of LTR transcriptional activity. (2006) (25)
- Role of HIV-1 envelope V3 loop cleavage in cell tropism. (1993) (25)
- Molecular and clinical assessment in the treatment of AIDS Kaposi sarcoma with valproic Acid. (2009) (25)
- Mechanism of action of N-butyl deoxynojirimycin in inhibiting HIV-1 infection and activity in combination with nucleoside analogs. (1993) (24)
- Phase I study of indicine N-oxide in patients with advanced cancer. (1982) (24)
- Relationship between productive HIV-1 infection of macrophages and CCR5 utilization. (1999) (24)
- Interferon-associated, dsRNA-dependent enzyme activities in a mutant 3T6 cell engaged in the semiconstitutive synthesis of interferon (1978) (24)
- Outcome of patients with relapsed/refractory acquired immune deficiency syndrome-related lymphoma diagnosed 1999–2008 and treated with curative intent in the AIDS Malignancy Consortium (2012) (23)
- Interferon as an Inhibitor of Cell Growth: Studies with Mouse Melanoma Cells (1980) (23)
- Effect of treatment of Strongyloides infection on HTLV‐1 expression in a patient with adult T‐cell leukemia (2007) (23)
- AIDS-Related Kaposi Sarcoma, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology. (2019) (22)
- Plasmablastic lymphoma is treatable in the HAART era. A 10 year retrospective by the AIDS Malignancy Consortium (2016) (22)
- Alpha Interferon Inhibits Human T-Cell Leukemia Virus Type 1 Assembly by Preventing Gag Interaction with Rafts (2003) (22)
- CHEMOTHERAPY FOR HIV-ASSOCIATED NON-HODGKIN LYMPHOMA (HIV-NHL) IN COMBINATION WITH HIGHLY ACTIVE ANTIRETROVIRAL THERAPY (HAART) IS NOT ASSOCIATED WITH EXCESSIVE TOXICITY. (1999) (22)
- Measurement of human immunodeficiency virus load and its relation to disease progression. (1989) (22)
- Inhibition of HIV and SIV infectivity by blockade of alpha-glucosidase activity. (1991) (22)
- Immortalization of T Lymphocytes by Human T-Cell Leukemia Virus Type 1 Is Independent of the Tax-CBP/p300 Interaction (2000) (21)
- A novel inducible expression system to study transdominant mutants of HIV-1 Vpr. (2001) (21)
- Antiviral activity of a Rac GEF inhibitor characterized with a sensitive HIV/SIV fusion assay. (2007) (21)
- Akt Pathway Activation by Human T-cell Leukemia Virus Type 1 Tax Oncoprotein* (2015) (21)
- Interaction of Human Immunodeficiency Virus Type 2 Vpx and Invariant Chain (2000) (21)
- Inducible nitric oxide synthase mediates DNA double strand breaks in Human T-Cell Leukemia Virus Type 1-induced leukemia/lymphoma (2015) (21)
- Specificity of polymerase chain amplification reactions for human immunodeficiency virus type 1 DNA sequences. (1989) (20)
- Human T cell lymphotropic virus-associated leukemia/lymphoma (2005) (20)
- Mutation of critical serine residues in HIV-1 matrix result in an envelope incorporation defect which can be rescued by truncation of the gp41 cytoplasmic tail. (2009) (20)
- Structure and expression of the human T-cell leukemia virus type 1 envelope protein. (1994) (20)
- PD-1 Inhibitor Therapy in Adult T-Cell Leukemia-Lymphoma. (2018) (20)
- Association of primate T-cell lymphotropic virus infection of pig-tailed macaques with high mortality. (2002) (20)
- Post-formulation peptide drug loading of nanostructures for metered control of NF-κB signaling. (2011) (19)
- Alterations in spliced and unspliced HIV-1-specific RNA detection in peripheral blood mononuclear cells of individuals with varying CD4-positive lymphocyte counts. (1993) (19)
- Adult T cell leukemia lymphoma. (2004) (18)
- Dynamic host immune response in virus-associated cancers (2019) (18)
- Adult T-Cell Leukemia/Lymphoma. (2017) (18)
- An activating mutation of interferon regulatory factor 4 (IRF4) in adult T-cell leukemia (2018) (17)
- Brentuximab vedotin with AVD shows safety, in the absence of strong CYP3A4 inhibitors, in newly diagnosed HIV-associated Hodgkin lymphoma (2017) (17)
- PDZ domain-binding motif of Tax sustains T-cell proliferation in HTLV-1-infected humanized mice (2018) (17)
- Modulation of β-Catenin and E-Cadherin Interaction by Vpu Increases Human Immunodeficiency Virus Type 1 Particle Release (2008) (16)
- Transgenic mouse models for HTLV-I infection. (1996) (16)
- Analysis of HIV-2 Vpx by modeling and insertional mutagenesis. (2006) (16)
- Studies of the immortalizing activity of HTLV type 1 Tax, using an infectious molecular clone and transgenic mice. (2000) (16)
- Simian immunodeficiency virus negative factor suppresses the level of viral mRNA in COS cells (1991) (16)
- HIV life cycle and genetic approaches (1993) (16)
- Familial adult T‐cell leukemia/lymphoma (1990) (15)
- HIV type 2 Vpx interaction with Gag and incorporation into virus-like particles. (2001) (15)
- The N-terminal matrix domain of HIV-1 Gag is sufficient but not necessary for viral protein U-mediated enhancement of particle release through a membrane-targeting mechanism. (2000) (14)
- Distinct Human Immunodeficiency Virus Strains in the Bone Marrow Are Associated with the Development of Thrombocytopenia (1999) (14)
- HTLV-1 viral oncogene HBZ induces osteolytic bone disease in transgenic mice (2017) (14)
- Adverse prognostic influence of hepatitis b virus infection in acute lymphoblastic leukemia (1986) (14)
- Sequence heterogeneity of Nef transcripts in HIV-1-infected subjects at different stages of disease. (1996) (14)
- Treatment of chemotherapy-resistant advanced ovarian cancer with a combination of cyclophosphamide, hexamethylmelamine, adriamycin, and cis-diamminedichloroplatinum (CHAP). (1981) (14)
- Evolution of Sequence Divergence among Human Immunodeficiency Virus Type 1 Isolates Derived from a Blood Donor and a Recipient (1993) (14)
- The human T-cell leukemia virus type-1 p30II protein activates p53 and induces the TIGAR and suppresses oncogene-induced oxidative stress during viral carcinogenesis. (2018) (13)
- Molecular biology of human T cell leukemia virus. (2020) (13)
- Complete nucleotide sequences of functional clones of the virus associated with the acquired immunodeficiency syndrome, HTLV-III/LAV. (1987) (13)
- HTLV-1 CTCF-binding site is dispensable for in vitro immortalization and persistent infection in vivo (2019) (13)
- In vivo analysis of replication and immunogenicity of proviral clones of human T-lymphotropic virus type 1 with selective envelope surface-unit mutations. (2005) (13)
- HTLV-1 Tax-1 interacts with SNX27 to regulate cellular localization of the HTLV-1 receptor molecule, GLUT1 (2019) (13)
- Pathogenesis and treatment of human T-cell leukemia virus infection (2005) (13)
- Interaction of HIV-1 gag and membranes in a cell-free system. (2002) (12)
- Characterization of Envelope Glycoprotein Mutants for Human T-Cell Leukemia Virus Type 1 Infectivity and Immortalization (2001) (12)
- HIV-1 determinants of thrombocytopenia at the stage of CD34+ progenitor cell differentiation in vivo lie in the viral envelope gp120 V3 loop region. (2010) (12)
- The TP53-Induced Glycolysis and Apoptosis Regulator mediates cooperation between HTLV-1 p30II and the retroviral oncoproteins Tax and HBZ and is highly expressed in an in vivo xenograft model of HTLV-1-induced lymphoma. (2018) (12)
- Chemotherapy of Recurrent Ovarian Carcinoma with cis‐Dichlorodiammine Platinum II and Adriamycin (1980) (12)
- The Dual-Specificity Kinase DYRK1A Modulates the Levels of Cyclin L2 To Control HIV Replication in Macrophages (2019) (11)
- HIV-2 Vpx Protein Interacts with Interferon Regulatory Factor 5 (IRF5) and Inhibits Its Function* (2014) (11)
- Safety and Preliminary Efficacy of Vorinostat With R-EPOCH in High-risk HIV-associated Non-Hodgkin’s Lymphoma (AMC-075) (2018) (11)
- HIV-1 V3 envelope sequences required for macrophage infection. (1995) (11)
- Biology and molecular biology of human immunodeficiency virus (1992) (11)
- Acetylation of the c-MYC oncoprotein is required for cooperation with the HTLV-1 p30(II) accessory protein and the induction of oncogenic cellular transformation by p30(II)/c-MYC. (2015) (11)
- Abstract CT118: Phase I study of defactinib combined with pembrolizumab and gemcitabine in patients with advanced cancer: Experiences of pancreatic ductal adenocarcinoma (PDAC) patients (2020) (11)
- Dynamic host immune response in virus-associated cancers (2019) (11)
- A lymphoproliferative disorder caused by human T-lymphotropic virus type I. Demonstration of a continuum between acute and chronic adult T-cell leukemia/lymphoma. (1987) (10)
- HTLV-1 viral oncogene HBZ drives bone destruction in adult T cell leukemia. (2019) (10)
- Role of Wild-type and Recombinant Human T-cell Leukemia Viruses in Lymphoproliferative Disease in Humanized NSG Mice. (2018) (10)
- Heparanase Blockade as a Novel Dual-Targeting Therapy for COVID-19 (2022) (10)
- Splicing Factor 3B Subunit 1 Interacts with HIV Tat and Plays a Role in Viral Transcription and Reactivation from Latency (2018) (10)
- IL-15 deficient Tax mice reveal a role for IL-1α in tumor immunity (2014) (9)
- Novel interactions between the HTLV antisense proteins HBZ and APH-2 and the NFAR protein family: Implications for the HTLV lifecycles. (2016) (9)
- Substitution of HIV Type 1 Nef with HTLV-1 p12. (2004) (9)
- Evolution of coreceptor utilization to escape CCR5 antagonist therapy (2016) (9)
- IL-15 Deficient Tax Mice Reveal a Role for IL-1α in Tumor Immunity (2014) (9)
- Tet-inducible lymphoma in a new Tax transgenic mouse model (2011) (8)
- Formation of noninfectious HIV-1 virus particles lacking a full-length envelope protein. (1991) (8)
- Conference Highlights of the 16th International Conference on Human Retrovirology: HTLV and Related Retroviruses, 26–30 June 2013, Montreal, Canada (2014) (8)
- Structure and expression of the c-sis gene and its relationship to sporadic meningiomas. (1991) (8)
- Interferon regulatory factor 4 as a therapeutic target in adult T-cell leukemia lymphoma (2020) (7)
- JAK blockade and HTLV. (2011) (7)
- The Smac mimetic RMT5265.2HCL induces apoptosis in EBV and HTLV-I associated lymphoma cells by inhibiting XIAP and promoting the mitochondrial release of cytochrome C and Smac. (2012) (7)
- Trans-activation of long terminal repeat sequence-mediated gene expression is not a property of type D retrovirus replication. (1987) (7)
- 1023MO AMC 095: A report of nivolumab (nivo) in advanced HIV associated solid tumours (ST) (2020) (7)
- Molecular biology and pathogenesis of HIV infection (1993) (7)
- Molecular characterization of human T-lymphotropic leukemia virus type III associated with the acquired immunodeficiency syndrome. (1984) (7)
- Response-adapted therapy with infusional EPOCH chemotherapy plus rituximab in HIV- associated, B-cell non-Hodgkin's lymphoma. (2020) (6)
- Safety and Efficacy of Brentuximab Vedotin in Combination with AVD in Stage II-IV HIV-Associated Classical Hodgkin Lymphoma: Results of the Phase 2 Study, AMC 085 (2019) (6)
- Genetic determinants controlling HIV-1 tropism for CD4-/GalCer+ human intestinal epithelial cells (1996) (6)
- Transcription Factors NF-KB and AP-1 in Human T Cells In Vitro after T-Cell Receptor Stimulation (6)
- Epigenomic regulation of human T-cell leukemia virus by chromatin-insulator CTCF (2021) (6)
- Genetic subgroups inform on pathobiology in adult and pediatric Burkitt lymphoma (2021) (6)
- Tracking the Assembly Pathway of Human Immunodeficiency Virus Type 1 Gag Deletion Mutants by Immunogold Labeling (2001) (6)
- A Pooled Analysis of 1,546 Patients with HIV-Associated Lymphoma: Assessment of Lymphoma-, HIV-, and Treatment-Specific Factors On Clinical Outcomes (2012) (5)
- Inhibitors of HIV protease based on modified peptide substrates (1990) (5)
- Germinal epimutation of Fragile Histidine Triad (FHIT) gene is associated with progression to acute and chronic adult T-cell leukemia diseases (2021) (5)
- Analogs of 3'-amino-3'-deoxyadenosine inhibit HIV-1 replication. (1989) (5)
- V1 and V2 Domains of HIV Envelope Contribute to CCR5 Antagonist Resistance (2019) (4)
- Response-Adapted Therapy with Infusional EPOCH Chemotherapy Plus Rituximab in HIV-Associated, B-Cell Non-Hodgkin's Lymphoma (2019) (4)
- The HTLV-1 hbz antisense gene indirectly promotes tax expression via down-regulation of p30-II mRNA (2011) (4)
- The Past, Present, and Future of a Human T-Cell Leukemia Virus Type 1 Vaccine (2022) (4)
- Functional analysis of HIV1 and SIV Nef proteins. (1992) (4)
- HIV-2 viral protein X (Vpx) ubiquitination is dispensable for ubiquitin ligase interaction and effects on macrophage infection. (2012) (4)
- CD3-dependent lymphocyte activation by human T cell leukaemia virus type I-producing T cells. (1994) (4)
- Nucleotide Sequence Analysis of a Variant Human T-Cell Leukemia Virus ( HTLV-Ib ) Provirus with a Deletion in pXI (3)
- Sera from HIV-1 infected individuals in all stages of disease preferentially recognize the V3 loop of the prototypic macrophage-tropic glycoprotein gp120 ADA. (1995) (3)
- Targeting NF-κB with Nanotherapy in a Mouse Model of Adult T-Cell Leukemia/Lymphoma (2021) (3)
- AMC-085: A Pilot Trial of AVD and Brentuximab Vedotin in the Upfront Treatment of Stage II-IV HIV-Associated Hodgkin Lymphoma. A Trial of the AIDS Malignancy Consortium (2015) (3)
- AMC075: A randomized phase II trial of vorinostat with R-EPOCH in aggressive HIV-related NHL. (2018) (3)
- The human T-cell leukemia virus type-1 tax oncoprotein dissociates NF-κB p65RelA-Stathmin complexes and causes catastrophic mitotic spindle damage and genomic instability. (2019) (2)
- Analysis of p 53 Inactivation in a Human T-Cell Leukemia Virus Type 1 Tax Transgenic Mouse Model (2001) (2)
- Defactinib, pembrolizumab, and gemcitabine in patients with advanced treatment refractory pancreatic cancer: A phase I, dose escalation, and expansion study. (2022) (2)
- Messenger RNA methylation, translation and degradation in extracts of interferon-treated cells. (1977) (2)
- Human immunodeficiency virus-associated thrombocytopenic purpura: The reply (1989) (2)
- GENETIC ORGANIZATION OF HIV (1996) (2)
- A Randomized Trial of EPOCH-Based Chemotherapy with Vorinostat for Highly Aggressive HIV-Associated Lymphomas: Updated Results Evaluating Impact of Diagnosis-to-Treatment Interval (DTI) and Pre-Protocol Systemic Therapy on Outcomes (2019) (2)
- Demonstration ofTwoDistinct Cytopathic Effects withSyncytium Formation-Defective HumanImmunodeficiency Virus Type1 Mutants (1991) (2)
- Advanced Heart Failure Treated with Continuous-Flow Left Ventricular Assist Device; Intrapericardial Left Ventricular Assist Device for Advanced Heart Failure; Increase in Left Ventricular Assist Device Thrombosis. (2018) (2)
- Epigenetic Regulation of Human T-Cell Leukemia Virus Gene Expression (2021) (2)
- Effects of mutant Vpr/Vpx on HIV-2 assembly demonstrated by immunoelectron microscopy. (2001) (2)
- Phase 1b trial of anti-VEGF/PDGFR vorolanib combined with immune checkpoint inhibitors in patients with advanced solid tumors (2022) (2)
- Human T-Cell Leukemia Virus Type 1 ( HTLV-1 ) Tax Requires CADM 1 / TSLC 1 for Inactivation of the NF-κ B Inhibitor A 20 and Constitutive NF-κ B Signaling (2016) (1)
- A phase 1/PK study of Sunitinib with highly active antiretroviral therapy (HAART) in HIV+ patients with solid tumors: AIDS malignancy consortium study 061 (2012) (1)
- Wip1 and p53 contribute to HTLV-1 Tax-induced tumorigenesis (2012) (1)
- Akt activation by human T-cell leukemia virus tax oncoprotein (2015) (1)
- Tax inflicts DNA damage through activation of Nitric Oxide production (2014) (1)
- Book Review Human Cancer Viruses: Principles of Transformation and Pathogenesis (Translational Research in Biomedicine. Vol. 1.) Edited by John Nicholas, Kuan-Teh Jeang, and T.-C. Wu. 244 pp., illustrated. Basel, Switzerland, Karger, 2008. $212. 978-3-8055-8576-7 (cloth); 978-3-8055-8577-4 (e-book). (2009) (1)
- Predicting the future: adult T-cell leukemia. (2020) (1)
- Highlights of the 16 th International Conference on Human Retrovirology : HTLV and Related Retroviruses , 26 – 30 June 2013 , Montreal , Canada (2015) (1)
- Evolution of Multiple Domains of the HIV-1 Envelope Glycoprotein during Coreceptor Switch with CCR5 Antagonist Therapy (2022) (1)
- Tolerability of paclitaxel/carboplatin (PCb) in solid tumor patients (pts) infected with HIV. (2017) (1)
- Accumulation of NFkB1 (p105) and NFkB2 (p100) Is Essential for Apoptosis Induced by Proteasome Inhibition in a Lymphoma Model. (2005) (1)
- Erratum to: ‘Mutation of epigenetic regulators TET2 and MLL3 in patients with HTLV-I-induced acute adult T-cell leukemia’ (2016) (1)
- High frequency of identical clonal immunoglobulin DNA in pre-treatment tumor and plasma from untreated patients with HIV-associated lymphoma: prospective multicenter trial of the AIDS malignancies consortium (AMC 064) (2017) (1)
- IL-15 deficiency promotes tumor growth in tax transgenic mice (2011) (1)
- Phase II trials of cetuximab plus combined modality therapy (CMT) in squamous cell carcinoma of the anal canal (SCCAC) with and without human immunodeficiency virus (HIV) infection. (2016) (1)
- Biomarkers and Preclinical Models for Adult T-Cell Leukemia-Lymphoma Treatment (2019) (1)
- Genomic alterations using OncoScan in adult T-cell leukemia/lymphoma: A characterization of 69 cases from Peru, the United States, Brazil, and Spain (2018) (1)
- ANGIOGENESIS INHIBITOR COL‐3 IN THE TREATMENT OF HIV‐RELATED KAPOSI'S SARCOMA: A PHASE I AIDS MALIGNANCY CONSORTIUM STUDY.: ABSTRACT 75 (2000) (1)
- Conference Highlights of the 16th International Conference on Human Retrovirology: HTLV and Related Retroviruses, 26–30 June 2013, Montreal, Canada (2014) (1)
- A role for an HTLV-1 vaccine? (2022) (1)
- Vpx is Critical for SIVmne infection of pigtail macaques (2012) (1)
- AIDS malignancy consortium (AMC) study 061: A phase I/PK study of sunitinib (S) with highly active antiretroviral therapy (HAART) in HIV+ patients with solid tumors. (2011) (1)
- Prospective phase I study of nab-paclitaxel plus gemcitabine with concurrent MR-guided IMRT in patients with locally advanced or borderline resectable pancreatic cancer. (2016) (0)
- A pooled analysis of 1,144 patients with HIV-associated lymphoma: Assessment of lymphoma-, HIV-, and treatment-specific factors on clinical outcomes. (2012) (0)
- The effects of XMRV gene expression on the mouse prostate (2011) (0)
- Bioluminescence Imaging of Spontaneous Lymphomas and Contribution of Distinct NFκB Pathways. (2006) (0)
- Germinal epimutation of Fragile Histidine Triad (FHIT) gene is associated with progression to acute and chronic adult T-cell leukemia diseases (2021) (0)
- Ability to Elicit Secretion of TNF-Differences Among HIV-1 Variants in Their Ratner (2000) (0)
- Abstract LB-127: HTLV-1 Tax inflicts severe DNA damage through the activation of nitric oxide production: A credible pathway for transformation of HTLV-1 infected cells. (2013) (0)
- Targeting xIAP Is More Important Than Bcl-Xl in Lymphomas with Constitutive Activation of NF-kB. (2006) (0)
- Mechanism of leukemogenesis by human T-cell leukemia virus types I and II: role of the lor gene. (1987) (0)
- Post‐formulation of peptide‐nanostructures for metered control of NF‐kB signaling (2011) (0)
- Tax inflicts DNA damage through activation of Nitric Oxide production (2014) (0)
- Pertussis and Pertussis Vaccines in Adults (2016) (0)
- Structure and Expression of the csis Gene and Its Relationship to Sporadic Meningiomas 1 (2006) (0)
- HIV Preintegration Complexes (2007) (0)
- LYMPHOPROLIFERATIVE DISEASE IN TAX TRANSGENIC MICE (1999) (0)
- SHORT COMMUNICATION Sequence Heterogeneity of Nef Transcripts in HIV-1-Infected Subjects at Different Stages of Disease (1996) (0)
- Contribution of Inducible Nitric Oxide Synthase to the Transformation of HTLV-1 Infected CD4+ T-Cells (2015) (0)
- Induction of the G (cid:2) q Signaling Cascade by the Human Immunodeficiency Virus Envelope Is Required for Virus Entry (cid:1) (2008) (0)
- Tumorigenesis with transgenic expression of human T/cell leukemia virus Tax (2003) (0)
- Development of an RNA Assay to Access HIV-1 Latency. (1991) (0)
- Mechanism of Cytotoxicity of the AIDS (Acquired Immunodeficiency Syndrome) Virus, HTLV-III/LAV (1988) (0)
- Human T Cell Lymphotropic Viruses and Their Family of Diseases (1986) (0)
- Mechanism of Cytotoxicity of the AIDS Virus, HTLV-III/LAV (1990) (0)
- mutations human T-lymphotropic virus type 1 with selective envelope surface-unit In vivo analysis of replication and immunogenicity of proviral clones of (2013) (0)
- Interferon regulatory factor 4 as a therapeutic target in adult T-cell leukemia lymphoma (2020) (0)
- Structure and Function of the Human Retroviruses (1986) (0)
- Cloning of Human Oncogenes (1985) (0)
- Infection through PKR Activation Novo De T-Lymphotropic Virus Type 1 and 2 Alpha Interferon Restricts Human (2013) (0)
- Abstract 3285: HTLV-1 viral oncogene Hbz induces leukemia with osteolytic bone involvement in mice (2016) (0)
- Patient derived HIV-1 Env Amplicons Demonstrate Trophic Shift from CCR5 to CXCR4 Use (2011) (0)
- IRF-4 and Interferon Resistance in Adult T-Cell Leukemia/Lymphoma. (2006) (0)
- Clinicopathologic characteristics, prognostic and predictive biomarkers in adult T-cell leukemia/lymphoma (ATLL): A characterization of 79 cases from the Western Hemisphere (2018) (0)
- A phase 1/PK study of Sunitinib with highly active antiretroviral therapy (HAART) in HIV+ patients with solid tumors: AIDS malignancy consortium study 061 (2012) (0)
- Structure and Function of HIV and SIV Nef Proteins (1991) (0)
- HTLV-1 CTCF-binding site is dispensable for in vitro immortalization and persistent infection in vivo (2019) (0)
- HumanImmunodeficiency VirusType1NefProtein Inhibits NF-KBInduction inHuman T Cells (1992) (0)
- Erratum to: ‘Mutation of epigenetic regulators TET2 and MLL3 in patients with HTLV-I-induced acute adult T-cell leukemia’ (2016) (0)
- ROLE OF TAX ACTIVATION OF CELLULAR PROMOTERS IN IMMORTALIZATION OF T-LYMPHOCYTES BY HTLV-I (1999) (0)
- Structure and Expression of the c-sis Gene and Its Relationship to Sporadic Meningiomas1 (2006) (0)
- SimianImmunodeficiency VirusNegative FactorSuppresses the LevelofViral mRNA inCOS Cells (1991) (0)
- Erratum: Limited sequence variation in human T-lymphotropic virus type 1 isolates from North American and African patients (Virology (1991) 182 (111- 123)) (1992) (0)
- Development of a Sensitive DNA Assay for the AIDS Virus, HTLV-III/LAV (1989) (0)
- Mutation of epigenetic regulators TET2 and MLL3 in patients with HTLV-I-induced acute adult T-cell leukemia (2016) (0)
- Adult T-Cell Leukemia-Lymphoma Presenting Concurrently with Myelopathy (2022) (0)
- Safety and Tolerability of Carboplatin and Paclitaxel in Cancer Patients with HIV (AMC-078), an AIDS Malignancy Consortium (AMC) Study (2022) (0)
- Clinical Characteristics and Outcomes of Infection with Human T-Cell Lymphotropic Virus (HTLV) in a Non-Endemic Area: A Single Institution Study (2022) (0)
- Mechanisms of Cytotoxicity of the Aids Virus (1991) (0)
- Combinations of isoform-targeted histone deacetylase inhibitors and bryostatin analogues display remarkable potency to activate latent HIV without global T-cell activation (2017) (0)
- Inducible nitric oxide synthase mediates DNA double strand breaks in Human T-Cell Leukemia Virus Type 1-induced leukemia/lymphoma (2015) (0)
- Akt activation by human T-cell leukemia virus tax oncoprotein (2015) (0)
- Chemotherapy f or H uman I mmunodeficiency Virus-Associated N on-Hodgkin's L ymphoma i n Combination W ith H ighly A ctive A ntiretroviral T herapy (2001) (0)
- Folic acid instead of leucovorin for 5-FU modulation? (1988) (0)
- HTLV-1, Cytokines,and Cancer (2007) (0)
- Phase I / II trial of dose adjusted EPOCH chemotherapy with bortezomib combined with integrase inhibitor therapy for HTLV-1 associated T-cell leukemia lymphoma (2015) (0)
- Genomic Stability: A Novel Function of NF-Kb in Lymphomas. (2009) (0)
- Phase I / II trial of dose adjusted EPOCH chemotherapy with bortezomib combined with integrase inhibitor therapy for HTLV-1 associated T-cell leukemia lymphoma (2015) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Lee Ratner?
Lee Ratner is affiliated with the following schools:
